UPDATED Apr 18, 2024
Over $1bn in market cap, profitable and undervalued based on cash flows.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MSFT | US$404.33 | -5.5% | 41.3% | US$3.1t | US$471.24 | PE36.4x | E12.6% | 0.7% | Software | ||
GOOGL | US$155.97 | -2.2% | 48.1% | US$1.9t | US$166.38 | PE26.3x | E11.8% | n/a | Media | ||
AMZN | US$181.28 | -2.5% | 73.8% | US$1.9t | US$209.61 | PE62x | E21.5% | n/a | Retail | ||
META | US$501.80 | -4.1% | 135.5% | US$1.3t | US$537.18 | PE32.7x | E14.4% | 0.4% | Media | ||
LLY | US$750.77 | -1.5% | 102.7% | US$672.6b | US$813.32 | PE129x | E27.1% | 0.7% | Pharmaceuticals & Biotech | ||
2330 | NT$804.00 | -2.0% | 56.7% | NT$20.9t | NT$882.12 | PE24.3x | E15.9% | 1.7% | Semiconductors | ||
AVGO | US$1,258.99 | -8.9% | 98.9% | US$594.4b | US$1,500.96 | PE50.4x | E23.4% | 1.7% | Semiconductors | ||
NOVO B | kr.862.70 | -0.8% | 54.3% | kr.3.8t | kr.904.20 | PE46x | E14.8% | 1.1% | Pharmaceuticals & Biotech | ||
JPM | US$181.25 | -7.3% | 28.7% | US$522.7b | US$205.38 | PB1.7x | E-1.6% | 2.5% | Banks | ||
WMT | US$59.26 | -1.4% | 17.8% | US$480.7b | US$65.08 | PE30.8x | E10.7% | 1.4% | Consumer Retailing | ||
XOM | US$118.52 | -2.7% | 2.5% | US$469.6b | US$129.77 | PE13x | E-0.6% | 3.2% | Energy | ||
UNH | US$478.99 | 6.4% | -1.5% | US$432.3b | US$568.23 | PE28.7x | E18.8% | 1.6% | Healthcare | ||
A005930 | ₩79,600.00 | -5.4% | 21.9% | ₩529.8t | ₩101,991.89 | PE37.4x | E27.4% | 1.8% | Tech | ||
PG | US$156.96 | -0.2% | 3.8% | US$367.0b | US$169.59 | PE25.5x | E7.4% | 2.4% | Household | ||
700 | HK$304.40 | -3.4% | -14.7% | HK$2.8t | HK$418.02 | PE22.7x | E15.0% | 1.1% | Media | ||
JNJ | US$145.74 | -2.0% | -10.9% | US$348.9b | US$172.53 | PE18.3x | E5.0% | 3.3% | Pharmaceuticals & Biotech | ||
HD | US$332.89 | -4.2% | 11.5% | US$329.8b | US$384.83 | PE21.8x | E4.2% | 2.7% | Retail | ||
ORCL | US$116.00 | -5.9% | 22.3% | US$326.2b | US$137.02 | PE30x | E14.7% | 1.4% | Software | ||
MRK | US$125.23 | -0.7% | 9.7% | US$317.6b | US$137.17 | PE869.1x | E25.9% | 2.5% | Pharmaceuticals & Biotech | ||
COST | US$711.25 | -2.9% | 40.7% | US$317.2b | US$768.10 | PE46.4x | E7.5% | 0.6% | Consumer Retailing | ||
ABBV | US$164.66 | -1.7% | 1.8% | US$290.8b | US$183.96 | PE60.5x | E23.1% | 3.8% | Pharmaceuticals & Biotech | ||
600519 | CN¥1,670.78 | 1.4% | -4.1% | CN¥2.1t | CN¥2,154.31 | PE28.1x | E12.8% | 3.0% | Food, Beverage & Tobacco | ||
CVX | US$156.40 | -3.9% | -8.4% | US$288.7b | US$180.53 | PE13.5x | E2.3% | 4.2% | Energy | ||
BAC | US$35.77 | -1.6% | 19.6% | US$281.4b | US$39.40 | PB1.1x | E6.2% | 2.7% | Banks |